Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents.
Cancer prevention
anticancer activity
bioavailability
combination treatment
drug transporters
drug-drug interactions
flavonoids
immunosuppression
Journal
American journal of cancer research
ISSN: 2156-6976
Titre abrégé: Am J Cancer Res
Pays: United States
ID NLM: 101549944
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
06
2019
accepted:
11
06
2019
entrez:
10
9
2019
pubmed:
10
9
2019
medline:
10
9
2019
Statut:
epublish
Résumé
Cancer is a diverse class of diseases characterized by uncontrolled cell growth with the potential to invade and spread to other parts of the body, and continues to be one of the leading causes of death worldwide. Conventional cancer treatment modalities include antitumor drugs, surgical resection, locally targeted therapies such as radiation therapy. Along with improved understanding of the molecular pathogenesis of various cancers, generation and the use of smart targeted anti-cancer drugs have been challenged. The need for novel therapeutic strategies remains paramount given the sustained development of drug resistance, tumor recurrence, and metastasis. Development of new strategies aimed at improving chemotherapy sensitivity and minimizing the adverse side effects is thus essential for obtaining satisfied therapeutic outcomes for patients and enhancing their quality of life. Emerging evidence has reported that many cancer patients use either herbs employed in complementary therapies or dietary agents that influence cellular signaling worldwide. Numerous components of edible plants, collectively termed phytochemicals that have beneficial effects for health, are being reported increasingly in the scientific literature. Of those, flavonoids have attracted much attention by virtue of its wide variety of biological functions including antioxidant, anti-inflammatory, and anticancer activity. In this review, we highlight the molecular mechanisms underlying its multiple pharmacological effects, especially focusing on cancer chemoprevention. We further discuss possible strategies to develop anticancer therapy by combining flavonoids nutraceuticals and conventional chemotherapeutic agents. We also highlight numerous pharmacokinetic challenges such as bioavailability, drug-drug interactions, which are still fundamental questions concerning its future clinical application.
Types de publication
Journal Article
Review
Langues
eng
Pagination
1517-1535Déclaration de conflit d'intérêts
None.
Références
Nat Immunol. 2005 Apr;6(4):345-52
pubmed: 15785760
Nutr Cancer. 2005;53(2):220-31
pubmed: 16573383
Urology. 2007 Oct;70(4):832-7
pubmed: 17991582
J Agric Food Chem. 2010 Apr 14;58(7):3957-64
pubmed: 20025272
Cancer Sci. 2010 Sep;101(9):1947-54
pubmed: 20550524
Molecules. 2011 Feb 10;16(2):1471-85
pubmed: 21311414
Neuro Oncol. 2011 Apr;13(4):393-400
pubmed: 21339188
Arch Pharm Res. 2011 Apr;34(4):607-13
pubmed: 21544726
J Hematol Oncol. 2012 Jan 24;5:1
pubmed: 22272800
Curr Mol Med. 2012 Feb;12(2):163-76
pubmed: 22280355
Cancer Res. 2012 May 1;72(9):2162-71
pubmed: 22549946
Oncol Rep. 2012 Nov;28(5):1875-82
pubmed: 22940758
Oncol Rep. 2013 Jan;29(1):103-8
pubmed: 23064420
Oncol Rep. 2013 Feb;29(2):474-80
pubmed: 23135489
Oncol Rep. 2013 Jun;29(6):2362-8
pubmed: 23563754
Int J Oncol. 2013 Jun;42(6):2069-77
pubmed: 23591552
Biochim Biophys Acta. 2013 Dec;1833(12):3448-3459
pubmed: 23770045
Cell Physiol Biochem. 2013;31(6):805-14
pubmed: 23816816
Nutrients. 2013 Aug 28;5(9):3367-87
pubmed: 23989753
J Surg Res. 2013 Nov;185(1):399-409
pubmed: 23993202
Int J Oncol. 2013 Dec;43(6):2046-56
pubmed: 24064676
Int J Oncol. 2013 Dec;43(6):1976-84
pubmed: 24126491
Nat Rev Mol Cell Biol. 2014 Jan;15(1):49-63
pubmed: 24355989
Int J Oncol. 2014 Mar;44(3):865-73
pubmed: 24379003
Chem Biol Interact. 2014 Apr 25;213:60-8
pubmed: 24525192
Mol Cell Biochem. 2014 May;390(1-2):235-42
pubmed: 24573886
Mol Vis. 2014 Mar 03;20:242-58
pubmed: 24623967
Eur J Pharmacol. 2014 Aug 15;737:57-69
pubmed: 24858369
Int J Oncol. 2014 Aug;45(2):843-52
pubmed: 24859772
Acta Pharmacol Sin. 2014 Jun;35(6):832-8
pubmed: 24902789
Asian Pac J Cancer Prev. 2014;15(13):5311-6
pubmed: 25040994
Oncotarget. 2014 Sep 30;5(18):8188-201
pubmed: 25149543
Cell Death Dis. 2014 Nov 06;5:e1509
pubmed: 25375374
Anticancer Agents Med Chem. 2015;15(6):728-35
pubmed: 25738871
Neoplasia. 2015 Feb;17(2):190-200
pubmed: 25748238
Int Immunopharmacol. 2015 Oct;28(2):859-65
pubmed: 25870037
Semin Cancer Biol. 2015 Dec;35 Suppl:S78-S103
pubmed: 25936818
Oncotarget. 2015 Jun 30;6(18):16379-95
pubmed: 25945840
Oncol Rep. 2015 Jul;34(1):431-8
pubmed: 25954945
Anticancer Agents Med Chem. 2015;15(9):1112-26
pubmed: 25986578
Int J Mol Sci. 2015 May 22;16(5):11728-49
pubmed: 26006245
Prostate. 2015 Oct;75(14):1518-25
pubmed: 26012728
Neurochem Int. 2015 Oct;89:120-5
pubmed: 26190180
Crit Rev Food Sci Nutr. 2016 Jul 29;56 Suppl 1:S4-S28
pubmed: 26463658
Oncol Rep. 2016 Jan;35(1):147-54
pubmed: 26497925
Am J Clin Nutr. 2016 Jan;103(1):184-91
pubmed: 26537935
BMC Cancer. 2015 Dec 16;15:958
pubmed: 26675309
J Agric Food Chem. 2016 Feb 3;64(4):725-37
pubmed: 26758628
Int J Oncol. 2016 Mar;48(3):1063-72
pubmed: 26794366
Cancer Cell Int. 2016 May 13;16:37
pubmed: 27182202
Am J Clin Nutr. 2016 Sep;104(3):704-14
pubmed: 27413131
Oncol Rep. 2016 Sep;36(3):1377-84
pubmed: 27431260
Adv Cancer Res. 2016;131:159-91
pubmed: 27451127
Eur J Cancer. 2016 Dec;69:216-222
pubmed: 27847222
Biochem Pharmacol. 2017 Jan 15;124:10-18
pubmed: 27984000
Cancer Cell Int. 2017 Jan 5;17:9
pubmed: 28070171
J Recept Signal Transduct Res. 2017 Aug;37(4):391-400
pubmed: 28264627
Am J Epidemiol. 2017 Jun 15;185(12):1304-1316
pubmed: 28472215
Integr Cancer Ther. 2018 Jun;17(2):511-523
pubmed: 28627240
Chin J Cancer. 2017 Jun 19;36(1):50
pubmed: 28629389
Ann N Y Acad Sci. 2017 Jun;1398(1):152-167
pubmed: 28632894
Biomedicines. 2017 Jun 21;5(2):
pubmed: 28635679
Int J Oncol. 2017 Aug;51(2):587-598
pubmed: 28656245
Cell Death Dis. 2017 Jul 20;8(7):e2944
pubmed: 28726775
Int Immunopharmacol. 2017 Sep;50:291-304
pubmed: 28734166
Nutr Cancer. 2017 Nov-Dec;69(8):1119-1150
pubmed: 29083244
Nat Rev Cancer. 2018 Feb;18(2):117-127
pubmed: 29192213
Phytother Res. 2018 Mar;32(3):471-479
pubmed: 29193405
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1702-1707
pubmed: 29225170
Oncol Rep. 2018 Feb;39(2):687-694
pubmed: 29251326
Phytomedicine. 2018 Jan 15;39:100-110
pubmed: 29433671
Oncol Rep. 2018 May;39(5):2351-2357
pubmed: 29565448
Phytother Res. 2018 Aug;32(8):1530-1536
pubmed: 29635751
Molecules. 2018 Apr 24;23(5):null
pubmed: 29695122
Toxicol Lett. 2018 Sep 15;294:27-36
pubmed: 29753067
J Agric Food Chem. 2018 Jul 11;66(27):7181-7189
pubmed: 29905475
Cancer Cell Int. 2018 Aug 13;18:113
pubmed: 30123091
Chem Biol Interact. 2018 Oct 1;294:9-17
pubmed: 30125548
J Ethnopharmacol. 2019 Jan 10;228:82-91
pubmed: 30243825
Pharmacol Ther. 2019 Feb;194:107-131
pubmed: 30268770
Int J Oncol. 2018 Dec;53(6):2488-2502
pubmed: 30272276
Oncol Lett. 2018 Nov;16(5):6195-6201
pubmed: 30333884
Phytother Res. 2019 Feb;33(2):263-275
pubmed: 30402931
Naunyn Schmiedebergs Arch Pharmacol. 2019 Feb;392(2):177-187
pubmed: 30448926
Phytomedicine. 2018 Nov 15;50:35-42
pubmed: 30466990
BMC Cancer. 2018 Nov 26;18(1):1168
pubmed: 30477461
J Cell Physiol. 2019 Jul;234(7):11103-11118
pubmed: 30478904
Nutrients. 2018 Nov 26;10(12):null
pubmed: 30486290
J Cell Physiol. 2019 Jun;234(6):8203-8220
pubmed: 30500074
Prostate Int. 2018 Dec;6(4):126-135
pubmed: 30505814
Biomed Pharmacother. 2019 Jan;109:1181-1195
pubmed: 30551368
Biomed Pharmacother. 2019 Jan;109:1511-1522
pubmed: 30551403
Anticancer Res. 2019 Jan;39(1):57-66
pubmed: 30591440
Eur J Med Chem. 2019 Feb 15;164:193-213
pubmed: 30594677
Chem Biol Interact. 2019 Feb 25;300:91-100
pubmed: 30639267
Food Funct. 2019 Feb 20;10(2):703-712
pubmed: 30663726
J Agric Food Chem. 2019 Mar 6;67(9):2510-2518
pubmed: 30741544
Front Immunol. 2019 Jan 31;10:51
pubmed: 30766532
Biol Res. 2019 Feb 23;52(1):7
pubmed: 30797236
Biomed Pharmacother. 2019 Apr;112:108612
pubmed: 30798142
Eur J Pharmacol. 2019 Jun 5;852:231-243
pubmed: 30959046
Front Pharmacol. 2019 Mar 22;10:260
pubmed: 30967777
Biotechnol Adv. 2019 Apr 9;:null
pubmed: 30978386
J Exp Clin Cancer Res. 2019 Apr 15;38(1):162
pubmed: 30987642
Lancet Oncol. 2019 May;20(5):686-700
pubmed: 30987939